303 related articles for article (PubMed ID: 3044912)
1. Healing and relapse of severe peptic esophagitis after treatment with omeprazole.
Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG
Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912
[TBL] [Abstract][Full Text] [Related]
2. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.
Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ
Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
[TBL] [Abstract][Full Text] [Related]
4. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment.
Annibale B; Franceschi M; Fusillo M; Beni M; Cesana B; Delle Fave G
Hepatogastroenterology; 1998; 45(21):742-51. PubMed ID: 9684126
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
8. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
[TBL] [Abstract][Full Text] [Related]
9. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
Dupas JL; Houcke P; Samoyeau R;
Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
[TBL] [Abstract][Full Text] [Related]
11. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
12. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study.
Sontag SJ; Hirschowitz BI; Holt S; Robinson MG; Behar J; Berenson MM; McCullough A; Ippoliti AF; Richter JE; Ahtaridis G
Gastroenterology; 1992 Jan; 102(1):109-18. PubMed ID: 1727744
[TBL] [Abstract][Full Text] [Related]
13. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of omeprazole in reflux oesophagitis.
Dent J; Hetzel DJ; MacKinnon MA; Reed WD; Narielvala FM
Scand J Gastroenterol Suppl; 1989; 166():76-82; discussion 94. PubMed ID: 2690334
[TBL] [Abstract][Full Text] [Related]
15. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
Ladas SD; Tassios PS; Raptis SA
Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
[TBL] [Abstract][Full Text] [Related]
16. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L
Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
18. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
Chiba N
Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
